Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lubricating jelly is a sterile, water-soluble, non-medicated gel typically used in medical procedures to reduce friction and discomfort. In the specific context of a clinical trial conducted by the University of Tennessee (NCT00821145), it was utilized as a placebo control applied to the nares (nostrils) of trauma ICU patients colonized with Methicillin-resistant Staphylococcus aureus (MRSA). The study aimed to evaluate whether active decolonization using mupirocin ointment and chlorhexidine baths was more effective than a control regimen consisting of lubricating jelly and soap baths in preventing invasive MRSA infections. As a placebo, the lubricating jelly provides no pharmacological or antimicrobial activity, serving only as a physical control for the intranasal application of mupirocin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lubricating jelly (University of Tennessee).